CIL partners to provide more isotope-labeled proteins to pharma
Cambridge Isotope Laboratories (CIL) is working with Nexomics Biosciences to provide isotope-labeled proteins to nearly all of the world’s largest pharmaceutical companies.
Archives for January 30, 2014
Pfizer, Lilly and other giants team up to fight counterfeits
Big pharma rivals are joining forces to pursue a new generation of sophisticated counterfeiters, according to Pfizer and Eli Lilly.
Clarus says oral testosterone bulks muscles, not liver
Clarus Therapeutics has submitted to the FDA a testosterone replacement it claims overcomes the toxicity problems that have plagued other oral drugs like methyltestosterone.
CordenPharma certified to handle HPAPIs under SafeBridge safety programme
CordenPharma has received certification of Potent Compound Safety at a US plant and joins a growing list of drugmakers looking to assure HPAPI safety, according to SafeBridge Consultants.
IOM looks into new ways to share clinical trial data
The Institute of Medicine is conducting a consensus study to recommend guiding principles and a framework for the responsible sharing of clinical trial data before a final report is released in December 2014.
GVK Bio to move into US with Aragen Purchase
Asia’s leading small-molecule CRO GVK BIO will acquire the capital stock of US-based CRO Aragen Bioscience.
Catalent looks to go public with $100m IPO
Catalent has filed an initial public offering (IPO) with the SEC to raise $100m though this could reach upwards of $500m, according to one investment firm.
Demand for HPAPIs drives Patheon to invest $1m in UK facility
Increasing demand for HPAPIs has driven Patheon to invest in its Milton Park, UK manufacturing facility, the company says.